[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345916-105":59,"doc-detail-345916-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","genomic-context-of-mutations-in-mir142-in-blood-cancers-summary-and-integrative-analysis","Genomic context of mutations in MIR142 in blood cancers - summary and integrative analysis","","MIR142 is the most frequently mutated microRNA (miRNA) gene in cancer, with recurrent alterations especially in hematologic malignancies of lymphoid origin. Expressed at very high levels in blood cells, MIR142 supports key roles in development, differentiation, and maturation of lymphopoietic and hematopoietic lineages. The study compiles mutation frequency, precursor location, and functional consequences, then evaluates broader genomic context across thousands of cancers. Results reveal hotspot-driven, non-random patterns consistent with positive selection and clinical relevance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genomic-context-of-mutations-in-mir142-in-blood-cancers-summary-and-integrative-analysis/345916/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genomic-context-of-mutations-in-mir142-in-blood-cancers-summary-and-integrative-analysis/345916.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the article on MIR142?","Question",{"text":112,"@type":113},"The article summarizes and analyzes MIR142 mutations, including their frequency across cancers, their location within the MIR-142 precursor, and their biological consequences.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"In which cancers are MIR142 mutations most prevalent?",{"text":117,"@type":113},"MIR142 mutations are recurrently observed particularly in hematologic malignancies of lymphoid origin, including AML, CLL, DLBCL, FL, and other B-cell non-Hodgkin lymphomas.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the findings suggest about why MIR142 mutations occur?",{"text":121,"@type":113},"The mutation patterns concentrate in a distinct hotspot and vary by cancer type, indicating MIR142 alterations are not random consequences of increased mutational load but likely reflect positive selection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345916,1790421147,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Wegorek etal. Cellular & Molecular Biology Letters (2026) 31:127 [https://doi.org/10.1186/s11658-026-00933-9](https://doi.org/10.1186/s11658-026-00933-9)  \nCellular & Molecular Biology Letters  \nMINI REVIEW Open Access  \nGenomic context of mutations in MIR142 in blood cancers: summary and integrative analysis  \nWladyslaw Wegorek1†, Adrian Tire1†, Daniel Kuznicki1, Julia Richter2, Maciej Giefing3, Wolfram Klapper2, Piotr Kozlowski1* and Paulina Galka-Marciniak1*  \n†Wladyslaw Wegorek and Adrian Tire have contributed equally to this work.  \n*Correspondence:  \nPiotr Kozlowski[kozlowp@ibch.poznan.pl](kozlowp@ibch.poznan.pl)  \nPaulina Galka-Marciniak [pgalka@ibch.poznan.pl](pgalka@ibch.poznan.pl)[ ](pgalka@ibch.poznan.pl)1Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland 2Hematopathology Section, Department of Pathology, University Hospital SchleswigHolstein, Kiel, Germany  \n3Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland  \nAbstract  \nMIR142 is the most frequently mutated microRNA (miRNA) gene in cancer, with recurrent alterations observed particularly in hematologic malignancies of lymphoid origin. It is expressed at very high levels in blood cells and plays an essential role in the development, differentiation, and maturation of various lymphopoietic and hematopoietic lineages. To gain a deeper understanding of MIR142 mutations, we summarize all data on these mutations, including their frequency in different cancers, their location within the miR-142 precursor, and their functional consequences. We also analyzed MIR142 mutations within a broader genomic context in thousands of cancers, including hundreds of blood neoplasms. Our results show that the most prevalent mutations in the MIR142 gene originate from a clearly distinct hotspot in hematologic malignancies, concentrated mainly within the sequence of the secondary miR-142 precursor. We found substantial differences in mutation frequency and distribution across cancer types. This indicates that MIR142 alterations are not random consequences of an increased mutational load but are likely subject to positive selection, underscoring their biological and clinical significance.  \nKeywords miR-142, DLBCL, AML, Lymphoma, miRNA mutations, CLL  \nIntroduction  \nmiRNAs are short, noncoding RNA molecules that posttranscriptionally regulate the expression of many genes. They play an important role in cancer, where many miRNAs, either upregulated or downregulated, have been identified as regulators of important cancer-related processes. Still, however, very little is known about cancer somatic mutations in miRNA genes. Recently, utilizing a large cancer oncogenomic dataset generated by The Cancer Genome Atlas (TCGA; comprising over 10,000 cancer samples from more than 30 cancer types), as well as our own results of whole miRNome sequencing (WMS), we performed a comprehensive whole-genome analysis of somatic mutations in miRNA genes, defined as ~ 100-nt-long sequences encoding hairpin-shaped miRNA precursors, in cancer samples [1, 2]. Altogether, we detected over 10,000 mutations  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creat","cbCaij8clupR4hHA","https://ap.wps.com/l/cbCaij8clupR4hHA","pdf",2374267,14,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main focus of the article on MIR142?\",\"answer\":\"The article summarizes and analyzes MIR142 mutations, including their frequency across cancers, their location within the MIR-142 precursor, and their biological consequences.\"},{\"question\":\"In which cancers are MIR142 mutations most prevalent?\",\"answer\":\"MIR142 mutations are recurrently observed particularly in hematologic malignancies of lymphoid origin, including AML, CLL, DLBCL, FL, and other B-cell non-Hodgkin lymphomas.\"},{\"question\":\"What do the findings suggest about why MIR142 mutations occur?\",\"answer\":\"The mutation patterns concentrate in a distinct hotspot and vary by cancer type, indicating MIR142 alterations are not random consequences of increased mutational load but likely reflect positive selection.\"}]","Genomic context of mutations in MIR142 in blood cancers - summary and integrative analysis | PDF",1790059391,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9143aaedda166cc6e900cfd7a1ea204.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d80255a55636510560250d0d867dfe71.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ef55d08d6c11b33f17b1005c0179f87.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca224bee25c9a925db56c300e1f55111.webp",980,1306]